Health Effects Assessment Summary (HEAST) for
Hydrazine
CAS: 000302-01-2
| Summary of HEAST Information on-Line | ||||||||||||
| Carcinogenicity | ||||||||||||
|
| Inhalation [Slope Factor]: (see comment) | 1.7E+1 (mg/kg/day)-1 | |||
| Route: | Inhalation: intermittent | |||
| Target Organ / Cancer: | Nasal cavity / Tumors | |||
| Species | Experiment Length | EPA Group | ||
| Rat | 1 year | IRIS | ||
| References | ||||
| 1981 | Macewen J.D., E.H. Vernot, C.C. Haun, E.R. Kinkead and A. Hall, iii. 1981. Chronic inhalation toxicity of Hydrazine: Oncogenic effects. Air Force Aerospace Medical Research Laboratory, Wright-Patterson Air Force Base, OH. | |||
| 1987 | U.S. EPA. 1987. Carcinogen Risk Assessment Verification Endeavor (CRAVE) Work Group. | |||
| 1984 | U.S. EPA. 1984. Health and environmental effects profile for Hydrazine and Hydrazine Sulfate. Prepared by the Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Cincinnati, OH for the Office of Solid Waste and Emergency Response, Washington, DC. | |||
| Inhalation Slope Comment: | See Appendix A-II, Dose Conversions on HEAST. | |||
[ Risk Assessment Home ]
[ EPA Home |
OSWER Home | Superfund Home ]
[ Search EPA
| Search Superfund
| Whats New |
Contact Us ]
URL: http://risk.lsd.ornl.gov/epa/heast/heast_select.htm
This page was last updated on: March 1, 2000
Site maintained by: Office of Emergency and Remedial Response
Hofmann.Lee@epamail.epa.gov